{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.996","upperLimit":"1.000","value":"0.999"},{"groupId":"OG001","lowerLimit":"0.987","upperLimit":"0.999","value":"0.996"}]}],"title":"0.5 Year"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.994","upperLimit":"0.999","value":"0.998"},{"groupId":"OG001","lowerLimit":"0.985","upperLimit":"0.998","value":"0.994"}]}],"title":"1 Year"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.988","upperLimit":"0.996","value":"0.993"},{"groupId":"OG001","lowerLimit":"0.979","upperLimit":"0.995","value":"0.990"}]}],"title":"1.5 Year"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.979","upperLimit":"0.990","value":"0.985"},{"groupId":"OG001","lowerLimit":"0.973","upperLimit":"0.992","value":"0.985"}]}],"title":"2 Years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.958","upperLimit":"0.975","value":"0.968"},{"groupId":"OG001","lowerLimit":"0.942","upperLimit":"0.972","value":"0.960"}]}],"title":"3 Years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.935","upperLimit":"0.956","value":"0.947"},{"groupId":"OG001","lowerLimit":"0.931","upperLimit":"0.965","value":"0.950"}]}],"title":"4 Years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.925","upperLimit":"0.948","value":"0.937"},{"groupId":"OG001","lowerLimit":"0.907","upperLimit":"0.947","value":"0.929"}]}],"title":"5 Years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.913","upperLimit":"0.938","value":"0.927"},{"groupId":"OG001","lowerLimit":"0.897","upperLimit":"0.939","value":"0.921"}]}],"title":"6 Years"}],"denoms":[{"counts":[{"groupId":"OG000","value":"1865"},{"groupId":"OG001","value":"708"}],"units":"Participants"}],"description":"Overall survival was defined as the time from randomization to death from any cause.\n\nTime from the date of randomization to the date of death was expressed in Kaplan-Meier survival probability estimates. Patients without an event will be censored at the last assessment date.","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants received SC Herceptin by an assisted administration as 600 mg every 3 weeks for a total of 18 doses/cycles. Each dose of SC Herceptin was taken from a single-use vial and injected by needle/syringe.","id":"OG000","title":"Cohort A: SC Herceptin by Needle/Syringe"},{"description":"Participants received SC Herceptin as 600 mg every 3 weeks for a total of 18 doses/cycles. Each dose of SC Herceptin was administered from a pre-filled SID. The first administration was performed by an HCP. Subsequent doses were self-administered by participants who were willing and judged competent by the HCP.","id":"OG001","title":"Cohort B: SC Herceptin by SIDE"}],"paramType":"NUMBER","populationDescription":"ITT population: All randomized participants received at least one dose of drug and completed the follow up period","reportingStatus":"POSTED","timeFrame":"From Baseline to Time of Event (Up to Approximately 6 Years)","title":"Overall Survival Rate","type":"SECONDARY","unitOfMeasure":"Kaplan-Meier survival probability"}